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ABSTRACT
Background. 
diabetes and the general population. Such individuals also have a worse prognosis 
and risk factors associated with stroke and its subtypes in individuals with type 
unclear.
Aim. This study sought to examine the incidence and risk factors associated 
prognosis and related predictors following an incident stroke in individuals with 
Participants and methods. This study was conducted as part of the 
nationwide, multicenter FinnDiane Study, which aims to discover the genetic, 
were examined according to the same examination protocol. Individuals with 
Results. The incidence of stroke and its subtypes (i.e., ischemic stroke, lacunar 
infarction, and hemorrhagic stroke) increased with the presence of both severe 
diabetic retinopathy and advancing diabetic nephropathy. A long duration of 
diabetes, poor glycemic control, high systolic blood pressure, a history of smoking, 
and lower insulin sensitivity were all found to be independent risk factors for 
ischemic stroke, while high systolic blood pressure and a lower body mass index 
were found to increase the risk of hemorrhagic stroke, along with severe diabetic 
retinopathy and diabetic nephropathy. The risk factors associated with lacunar 
infarctions were determined to be similar to those associated with ischemic stroke. 
blood pressure, mean arterial pressure, and pulse pressure) were found to be 
risk of stroke increased in a linear fashion with increasing blood pressure, while 
potassium excretion. The overall likelihood of survival following an incident stroke 
following the stroke. The predictors of a worse outcome were found to be a stroke 
renal disease. 
Conclusions. 
of poorer health and have more diabetic complications, higher blood pressure, and 
stroke. Both elevated systolic blood pressure and diabetic kidney disease represent 
important risk factors with regard to the development of stroke. The prognosis 
terms of the prevention and treatment of stroke, it is important to identify these 
in addition to screening for albuminuria.
ABSTRAKT (ABSTRACT IN SWEDISH)
Bakgrund. 
Studiens målsättningar. Målsättningen med denna avhandling var att ut
Dessutom ville vi utreda vad prognosen är efter en stroke, samt vilka faktorer 
som påverkar den här prognosen.
Patienter och metoder. Den här avhandlingen är en del av den nationella 
det nationella vårdanmälningssystemet, baserat på den tionde upplagan av den 
patientjournaler samt radiologiska bilder på hjärnan.
Resultat.
systoliskt blodtryck och lågt kroppsmasseindex, tillsammans med diabetesnefro
De olika blodtryckskomponenterna, dvs systoliskt blodtryck, diastoliskt blodtryck, 
Slutsatser.
personer.
TIIVISTELMÄ (ABSTRACT IN FINNISH)
Tausta.
diabeteksessa on tästä huolimatta vähän. Lisäksi aivohalvauksen jälkeisen ennus
Tavoitteet. 
mikä on aivohalvauksen jälkeinen ennuste ja mitkä tekijät tähän vaikuttavat.
Aineisto ja menetelmät.
on kansallinen monikeskustutkimus, jonka tavoitteena on selvittää geneettisiä, 
kimuksen kyselylomakkeesta, kuolintodistuksista sekä kansallisesta Hoitoilmoi
Aivohalvaukset luokiteltiin alaluokkiin sairaskertomusten ja aivojen radiologisten 
Tulokset. Aivohalvauksen sekä alaluokkien (aivoinfarktit, lakunaariset infarktit 
diabeettinen retinopatia ja diabeteksen munuaistauti. Esiintyvyys oli sitä kor
keampi, mitä vaikeampi diabeteksen munuaistauti oli. Pitkä diabeteksen kesto, 
huono verensokeritasapaino, korkea systolinen verenpaine, tupakointitausta ja 
korkea systolinen verenpaine ja matala painoindeksi olivat diabeettisen retinopati
Lakunaarisen infarktin riskitekijät olivat samat kuin aivoinfarktin riskitekijät. 
renpaine, keskiverenpaine ja pulssipaine lisäsivät riskiä sairastua aivohalvaukseen 
nousun yhteydessä. Virtsaan erittyvä natrium ja kalium eivät vaikuttaneet aivo
neilla oli parempi ennuste verrattuna aivoverenvuotoon sairastuneilla, mikä nä
kyi varsinkin ensimmäisen vuoden aikana aivohalvauksen jälkeen. Ennustetta 
huonontavat tekijät olivat aivoverenvuoto, heikentynyt munuaisten toiminta ja 
varsinkin loppuvaiheen diabeteksen munuaistauti. 
Päätelmät.
ilman aivohalvausta, ja heillä on enemmän diabeettisia komplikaatioita, korke
munuaistauti vaikuttaa ennusteeseen suuresti. Aivohalvauksen ennaltaehkäisyn 
1 INTRODUCTION
and unfortunately, its incidence is still increasing. Indeed, it has been estimated 
as it also results in other metabolic disturbances, such as disturbances in blood 
diabetic neuropathy, represent the microvascular complications associated 
with diabetes. These chronic complications can have devastating consequences, 
including blindness and the need for dialysis treatment, kidney transplantations, 
macrovascular complications of diabetes and the resultant cardiovascular disease, 
gruesome, leading to impaired quality of life and excessive mortality in those 
increased. Stroke is, therefore, the disease that most commonly results in disability 
caused by the occlusion of the cerebral arteries, and hemorrhagic stroke, which 
is caused by the rupture of the cerebral blood vessels or aneurysms in the brain, 
lacunar infarction (i.e., stroke due to the occlusion of the large arteries) and 
lacunar infarction (i.e., the occlusion of a single perforating artery, which causes 
of stroke into strokes of ischemic or hemorrhagic origin is important because 
those studies, the incidence of the stroke subtypes (ischemic stroke, hemorrhagic 
to be a link between chronic kidney disease, retinal microvascular changes, and 
longer duration of diabetes, elevated systolic blood pressure, higher glycosylated 
hemoglobin A  (HbA
remains unclear how mildly decreased kidney function or moderately increased 
Elevated blood pressure is one of the strongest risk factors for stroke among both 
represents the maximum pressure the blood exerts against the artery walls when 
the heart beats, while the diastolic blood pressure represents the minimum 
pressure. With age, the systolic blood pressure increases in a linear fashion, while 
the diastolic blood pressure starts to decrease, mainly due to reduced vascular 
and diastolic blood pressures. This component naturally increases with age due to 
the described changes in the systolic and diastolic blood pressures, and it can be 
diabetes has not yet been studied. The risk of stroke increases in a linear fashion 
stroke, the male sex, and diabetes all predict a higher mortality rate in the general 
stroke also appears to be poor. In the only prior study concerning this issue, more 
study, meaning that further research is required. 
2 REVIEW OF THE LITERATURE
2.1 Diabetes mellitus
Diabetes mellitus is a chronic systemic disease characterized by elevated blood 
glucose levels (or hyperglycemia). This hyperglycemic condition may cause 
fatigue, excess urine production, systematic organ damage, and eventually, death. 
For centuries, no treatment was available for diabetes, and it was not until the 
2.1.1 Classification of diabetes
tolerance test, an HbA
hyperglycemia and a carbohydrate imbalance, but also results in a disturbance 
insulin resistance, or sometimes, a combination of the two. The two major types 
dependent on exogenous insulin for survival, and treatment with insulin is usually 
initiated immediately following diagnosis. Several genetic and environmental 
been proposed, which highlights the fact that diabetes is a heterogenous disease 
autoantibodies, metabolic derangements, and the age at onset. The intention 
2.1.2 Epidemiology of type 1 diabetes
it one of the most common chronic autoimmune diseases in the world. Finland 
lowest incidence is found in China and Venezuela, which both have an incidence of 
th 
st
although several theories exist. For instance, better health care and the adjustment 
of insulin treatment, as well as other factors that promote health, have led to 
increased survival. Furthermore, the increased overall survival rate has given 
rise to increased genetic survival and the passing on of genes related to diabetes. 
genetic predisposition toward the disease, other causes such as environmental 
2.1.3 Pathogenesis of type 1 diabetes
interactions of genes, viral infections, and other environmental factors are all 
within the pancreas (i.e., insulitis) remains unknown, although autoantibodies 
seem to play a role in activating the autoimmune response. Moreover, the triggers 
behind the autoimmune response in genetically prone individuals remain unclear. 
environmental factors responsible for the activation of autoantibody development. 
accordance with this theory, a vaccine against this type of virus has been shown 
the decrease in infectious diseases that results from better hygiene, health, and 
medical conditions during childhood leads to the inadequate development of the 
This hypothesis is supported by the fact that the incidence of other autoimmune 
diseases, such as allergies and asthma, have increased as a result of the loss of 
2.2 Chronic diabetic complications
complications. The hyperglycemic state and hypertension, among other things, 
blood vessels, resulting in coronary heart disease, stroke, and lower extremity 
smaller blood vessels, and they comprise diabetic nephropathy, retinopathy, and 
2.2.1 Diabetic nephropathy
Terminology. The preferred terminology concerning the diabetic microvascular 
at the time the studies included in this thesis were conducted, the preferred term 
was diabetic nephropathy, which is why diabetic kidney disease is referred to 
stages of diabetic nephropathy, that is, microalbuminuria, macroalbuminuria, 
today referred to as moderately increased albuminuria, or albuminuria category 
approach at the time the studies included in this thesis were conducted, the terms 
throughout.
Diabetes is the most common cause 
the case of diabetic nephropathy, the damaged kidneys lead to the loss of kidney 
function. The progression of diabetic nephropathy can eventually lead to complete 
kidney failure, leaving the individual in need of dialysis or a kidney transplant 
in order to survive. In diabetes, hyperglycemia and hypertension, among other 
glomeruli, which represent the functional part of the kidneys. This leads to 
in the urine, diabetic nephropathy can be divided into four stages: a normal 
urinary albumin excretion rate (UAER), microalbuminuria, macroalbuminuria, 
corresponding terminology is normal to mildly increased albuminuria, moderately 
increased albuminuria, severely increased albuminuria, and kidney failure, 
The development and progression of diabetic nephropathy usually takes decades. 
The Pittsburgh Epidemiology of Diabetes Complications (EDC) Study revealed 
of developing microalbuminuria and macroalbuminuria, thereby also reducing 
decades due to improved treatment options and the early detection of albuminuria 
and the regression of this complication is also possible. In a study conducted 
macroalbuminuria regressed to a lower category of albuminuria, while the risk 
of developing cardiovascular complications in these individuals also diminished 
Screening and diagnosis. The diagnosis of diabetic nephropathy is based 
on the amount of albumin in the urine. Screening for albuminuria is usually 
creatinine ratio from a random spot urine collection. Screening for albuminuria 
This is mainly due to confounding factors, such as infections, fever, strenuous 
exercise, congestive heart failure, and menstruation, which may cause transient 
collections for the detection of albumin are also possible, although they require 
people with microalbuminuria, which is now referred to as moderately increased 
 With 
Another way to describe and grade diabetic kidney disease involves kidney 
is considered to be more accurate than the other available methods because it 
TABLE 1. Stages of chronic kidney disease according to the eGFR stage and level of albuminuria, 
adapted from the Kidney Disease: Improving Global Outcomes and American Diabetes 
Association guidelines (60,72), and including terminology used in this thesis.
CKD risk categories according to 











CKD Stage eGFR  (mL/min/1.73 m2) < 30 mg
 30 and
 < 300 mg  300 mg
Stage 1 Normal or high  90
Stage 2 Mildly decreased 60–89
Stage 3a Mildly to moderately decreased 45–59
Stage 3b Moderately to mildly decreased 30–44
Stage 4 Severely decreased 15–29
Stage 5 Kidney failure < 15
The white color depicts a low risk of CKD progression, the light grey color a moderately increased 
risk, the medium grey color a high risk, and the dark grey color a very high risk. eGFR = estimated 
glomerular filtration rate, CKD = chronic kidney disease, UAER = urinary albumin excretion rate.
Risk factors. Elevated blood glucose and high blood pressure, which are both 
sex being found to increase the risk of the progression of diabetic nephropathy 
and macrovascular complications cluster within individuals, and the presence of 
diabetic retinopathy generally precedes the development of diabetic nephropathy 
Treatment. When it comes to managing diabetic nephropathy, annual screening 
for albuminuria is highly important. If, or when, microalbuminuria and diabetic 
nephropathy develop, the focus should be on treating the risk factors mentioned 
above. Intensive treatment and lowering both the blood glucose concentration 
development of diabetic nephropathy, and aggressive blood pressure treatment 
leads to the recovery of the kidneys, diminishes the need for dialysis treatment 
or kidney transplantation, and reduces the mortality rate linked to renal failure 
have been shown to not only protect the kidneys and reduce the risk of the 
progression of diabetic nephropathy, but also to lower the cardiovascular risk 
associated with this complication, leading to them being the agents of choice when 
neither hypertension nor albuminuria are present, these agents will not prevent 
urine, which leaves the individual in need of dialysis treatment or transplantation. 
. For those who are eligible, renal 
may be possible, resulting in the individual having restored kidney function 
transplantation is substantially better than survival after kidney transplantation 
2.2.2 Diabetic retinopathy
 In addition to being the most common 
microvascular complication of diabetes, diabetic retinopathy is the leading cause 
or diabetic maculopathy, which is caused by the thickening of the retina in the 
in the retina, or microaneurysms. As the complication progresses, intraretinal 
hemorrhages and cotton wool spots appear, while the blood vessels that nourish 
the retina may lose the ability to transport blood. In proliferative diabetic 
new blood vessels are fragile, and they have a tendency to bleed. Vision loss occurs 
partly due to this. Furthermore, the development of the new blood vessels leads to 
central vision can be impaired by the macular edema caused by increased vascular 
Risk factors. Diabetic retinopathy is closely associated with the duration of 
et al, no risk of developing proliferative diabetic 
Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions 
and Complications (DCCT/EDIC) showed that intensive treatment of the blood 
glucose decreased the risk of the progression of diabetic retinopathy by more than 
seems to be a genetic predisposition toward diabetic retinopathy. As observed in 
the same study, the severity of diabetic retinopathy is closely associated with the 
Screening, diagnosis, and treatment. Diabetic retinopathy is diagnosed 
by means of fundus photography or ophthalmoscopy. Screenings are performed 
regularly in individuals with diabetes in order to identify those who are at 
such as hypertension and dyslipidemia are key to the prevention and treatment 
glucose concentrations in those who have already developed retinopathy may 
develops, retinal laser treatment is required to mitigate vision disturbances and 
2.2.3 Diabetic neuropathy
As the most common of all the neuropathies worldwide, diabetic neuropathy 
most common form, and its symptoms include numbness, tingling and burning 
sensations, pain, weakness, loss of sensation, and loss of proprioception. The 
symptoms usually start distally in the lower extremities, before moving up to the 
Another form of diabetic neuropathy is autonomic neuropathy, which involves 
dangerous are the cardiovascular symptoms. These consist of resting tachycardia 
diabetic neuropathy focuses on improving glycemic control and pain management, 
2.2.4 Cardiovascular disease and macrovascular complications
Epidemiology of cardiovascular disease and coronary heart disease. 
In comparison to microvascular disease, macrovascular disease has been studied 
lower extremity artery disease) are pooled into a common cardiovascular endpoint 
termed cardiovascular disease. This macrovascular complication contributes to 
in these individuals, the incidence of coronary heart disease has remained 
et al found that the 
Microvascular complications, cardiovascular disease, and all-
cause mortality. When compared with individuals who have a normal UAER, 
microalbuminuria, the mildest form of diabetic nephropathy, doubles the risk 
diabetes, although it must be recognized that confounding factors were not taken 
coronary heart disease and stroke when compared with those without nephropathy 
et al
diabetic nephropathy. A particularly concerning fact is that the highest mortality 
et al found that the presence and the severity of chronic kidney disease increase 
Even though renal dysfunction is one of the strongest predictors of mortality 
the general population, mainly due to acute diabetes complications and ischemic 
disease. Diabetic retinopathy increases the risk of coronary heart disease when 
nephropathy is also present. The same is true for neuropathy. No independent 
associations between these two microvascular complications and coronary heart 
disease have been found, partly due to the strong relationship with diabetic 
Other risk factors for cardiovascular disease. As mentioned above, blood 
revealed in the Framingham Heart Study, the systolic blood pressure, among all 
the blood pressure components, has the strongest association with cardiovascular 
is an independent risk factor for coronary heart disease in individuals with type 
heart disease despite the elevated systolic blood pressure seen in the general 
Elevated HbA
coronary heart disease increases in a linear fashion with higher blood glucose 
, the risk of coronary 
the intensive treatment of the glucose level during the DCCT in individuals with 
DCCT study ended. The observed risk reduction was mostly attributable to the 
improved glucose levels during the DCCT, and it was sustained for a prolonged 
In terms of the diabetes duration and the risk of coronary heart disease in 
indicative of obesity, increases the risk of coronary heart disease, although no 
metabolic syndrome increases the risk of cardiovascular disease as well as the 
evidence of an association between insulin resistance and the risk of coronary 
While dyslipidemia is a strong risk factor for both cardiovascular disease and 
et al 
et al
Instead, higher fasting triglyceride levels were found to be modestly associated 
cholesterol levels were seen to linearly decrease the risk of coronary heart disease 
phenomenon is seen, meaning that the risk of coronary heart disease starts to 
2.3 Stroke
of neurological function due to a disruption to the blood circulation in the brain 
has been replaced with the term central nervous system. In addition to the brain, 
2.3.1 Classification and pathophysiology of stroke
Ischemic stroke.
lacunar or lacunar stroke based on the mechanism leading to the stroke (i.e., 
phenotypic characteristics of the clinical stroke syndrome and the radiological 
et 
al
circulation infarcts (TACI), partial anterior circulation infarcts (PACI), posterior 
et al 
mainly due to either atherosclerosis of the carotid artery or cardioembolism) or 
TABLE 2. Classification of ischemic stroke























et al (12) Non-lacunar stroke Lacunar stroke
Classification of ischemic stroke based on pathophysiology (TOAST), location (Bamford et al), and 
phenotype (Pantoni et al).
stroke due to damage to the cerebral small arteries, veins, arterioles, and 
capillaries that leads to either ischemia (manifesting as white matter lesions or 
vessel disease and lacunar strokes are less severe when compared with those of 
Figure 1A. Magnetic resonance image of a large cerebral infarction with hemorrhagic 
transformation, which is visible as the white area.
Hemorrhagic stroke. The two major hemorrhagic stroke subtypes are 
as bleeding into the brain parenchyma, which in some cases also extends into 
spontaneous rupture of the small blood vessels due to hypertension or cerebral 
malformations, of which arteriovenous malformations, cavernous angiomas, and 
secondary ICH include trauma to the head, tumors in the brain parenchyma, 
coagulopathy due to drug use or hemostatic/hematologic disorders, toxins (e.g., 
Figure 1B. Computed tomography image of an intracerebral hemorrhage, which is visible as 
the dense white area.
Subarachnoid hemorrhage (SAH), the other hemorrhagic stroke subtype, accounts 
coagulopathies (i.e., drug use or hemostatic/hematologic disorders), brain tumors, 
origin found in the case of ICH. Thus, the mechanisms and risk factors for these 
Transient ischemic attack. A preliminary form of stroke is a transient 
in many cases brain injury has been visible on the MRI of individuals with the 
classical symptoms of a TIA. Therefore, it has been proposed that a TIA should 
or retinal ischemia, with clinical symptoms typically lasting less than one hour, 
Pathophysiology of ischemic stroke. Ischemic stroke can be caused by 
thrombosis or embolus of the arteries, hypoperfusion, or venous thrombosis, which 
the majority of such changes, and the development of atherosclerosis continues 
of atherosclerosis begins with foam cells accumulating on the inside of the blood 
streaks enlarge when extracellular lipids, such as cholesterol and lipoproteins, are 
to the vascular walls usually develop at the branching points of the blood vessels, 
vessel walls include the development of atherosclerotic plaques, that is, the lipid 
may continue to grow and eventually occlude the blood vessel lumen, leading to 
thrombosis and the occlusion of either the large blood vessels or single perforating 
arteries. The plaques may also rupture, thereby causing emboli and occlusion. The 
formation of atherosclerotic plaques also weakens the blood vessel walls, which 
may lead to the formation of aneurysms or hemorrhage into the cerebral tissue 
In the case of extracranial carotid artery disease, the atherosclerotic plaques 
are formed mainly in the bifurcation area of the large carotid arteries that supply 
plaques can also rupture, thereby leading to emboli and the occlusion of smaller 
In terms of cardioembolic stroke, the thrombi or emboli formed in the cavities 
of the heart travel to the cerebral vasculature, where they cause the obstruction 
cardiac endothelium and disturbs the coagulation cascade, which promotes 
left atrium has a tubular structure with an appendage, and it is the formation of 
these thrombi causes similar damage to the cerebral tissue as seen in the case of 
tissue is dependent on the continuous supply of oxygen due to the lack of a 
causes cerebral edema and damage to the cerebral tissue 
tissue can be divided into the ischemic core, in which irreversible damage has 
occurred, and the surrounding penumbra, in which tissue salvation is feasible 
if the oxygen supply is restored. This penumbra is the primary target of the 
Pathophysiology of hemorrhagic stroke. Similar to ischemic stroke, 
hemorrhagic stroke causes hypoxia to the cerebral tissue due to the pressure 
As previously described, ICH is generally caused by hypertensive arteriolosclerosis, 
with high blood pressure causing smooth muscle cell proliferation, cell death, 
and collagen deposition, which leads to structurally weak blood vessel walls, 
cause of ICH, that is, amyloid angiopathy, is a state wherein the accumulation of 
amyloid plaques in the blood vessel walls leads to the degeneration of the smooth 
because the vast majority of SAH arise due to the rupture of saccular aneurysms. 
These aneurysms usually develop at the branching points of the major arteries 
in the circle of Willis, which is the cerebral arterial circle that supplies the blood 
degenerate due to hemodynamic stress. Eventually, the walls of the aneurysms 
break, resulting in bleeding into the subarachnoid space, and in some cases, into 
Hyperglycemia and stroke. Although stroke is generally considered to be 
a macrovascular complication, microvascular changes occur more frequently 
in several ways. For instance, chronic hyperglycemia, as is prevalent in those with 
vascular changes lead to the dysfunction of the microvasculature in the brain, 
up to hypoperfusion, hypoxia, and bleeding in the cerebral vasculature, which 
2.3.2 Diagnosis and treatment of stroke
Symptoms of stroke. The symptoms of stroke depend on which part of the 
typical symptoms of stroke include sudden unilateral weakness and/or numbness, 
and vertigo. The atypical and associated symptoms may vary, and they are usually 
a consequence of the stroke itself. These symptoms include blindness in one 
swallowing, headaches, confusion, uncontrolled limb movements, and altered 
Diagnosis of stroke. The diagnosis of stroke is clinical, and it is based on 
imaging is of great importance when it comes to determining the origin of a stroke, 
in addition to the location and extent of the resultant cerebral injury. The most 
case of ischemic stroke, the sensitivity of this technique can prove inadequate, 
additional diagnostic method should be considered if more than six hours have 
detection and diagnosis of stroke are key to a better prognosis. Atypical stroke 
features and symptoms, uncertainty regarding the onset of symptoms, or normal 
Treatment of ischemic stroke. The treatment of stroke depends on the 
subtype in question. The preferred treatment method for ischemic stroke is 
intravenous thrombolysis with recombinant tissue plasminogen activator in order 
to prevent the ischemic penumbra from becoming irreversibly damaged cerebral 
tissue plasminogen activator should be initiated within nine hours of the onset 
neurological imaging has been performed, this time limitation can be extended 
to treatment has shortened rapidly, improving the prognosis of these people. In 
room of the Helsinki University Central Hospital, which is a primary treatment 
Figure 2. Number of annually treated patients and median door-to-needle times. Annual 
patients, with those treated beyond 3 hours in red (bars, left axis) and median door-to-
needle time in minutes with interquartile range (line, right axis). Total n = 1,686. The projected 
number of patients for 2011 is based on the observed numbers of the first 6 months. 
Reprinted from Neurology, Meretoja et al, Reducing in-hospital delay to 20 minutes in 
stroke thrombolysis, pages 306 – 313. Copyright © 2012 American Academy of Neurology. 
Reprinted with permission from the American Academy of Neurology.
However, when it comes to proximal intracerebral artery occlusion, the intravenous 
method, whereby a device designed to recanalize the occluded artery is inserted 
into the femoral artery, has been developed and is currently the treatment method 
In the case of carotid stenosis, carotid endarterectomy is recommended in 
endarterectomy is a surgical procedure involving the removal of the carotid plaque 
of developing the complications of carotid endarterectomy, the stenting of the 
Treatment of hemorrhagic stroke. With regard to hemorrhagic stroke, 
the faster treatment is initiated, the better the outcome. The treatment goal for 
to minimize the cerebral damage. An important treatment strategy for ICH 
For selected people with large hematomas, surgical intervention and the removal 
pressure and the reversal of the anticoagulant treatment should be part of the 
antiplatelet therapy is recommended in the presence of a TIA. The treatment 
of hypertension and dyslipidemia are important in relation to the secondary 
2.3.3 Epidemiology of stroke
Incidence of stroke.
to continents, the highest incidence of stroke is found in Eastern Europe and Asia, 
of the major subtypes of stroke, namely ischemic and hemorrhagic stroke, also 
2.3.4 Epidemiology of stroke in people with diabetes
concerning the stroke subgroups are even scarcer due to the low number of 
Health Study conducted by Janghorbani et al
et al found 
et al
Stroke occurs at a younger age in individuals with diabetes than in the general 
the study by Janghorbani et al
the general population, while the risk increases even earlier in women with type 
only is the risk of ischemic stroke increased when compared with the general 
The ratio of the major stroke subtypes in individuals with diabetes is similar 
et al showed that lacunar stroke was 
et al
disease was found to be more common in young neurologically asymptomatic 
controls. Moreover, the presence of cerebral microbleeds was especially noticeable 
2.3.5 Risk factors for stroke and its subtypes
of studies regarding the role played by hypercholesterolemia in relation to the risk 
of stroke are somewhat inconsistent, with a clearer association between high blood 
cholesterol and an increased risk of stroke being seen in individuals younger than 
The metabolic syndrome is also an independent risk factor for stroke, increasing 
the risk of stroke. All these factors are more often seen in individuals living in 
industrial countries; therefore, the risk factors for stroke vary globally and are 
are also associated with an increased risk of this stroke subtype. The risk 
hypertension and diabetes seem to be more common in lacunar strokes, while 
risk factors similar to those for ischemic stroke have been found. These include an 
are also associated with an increased risk of hemorrhagic stroke. With regard 
2.3.6 Risk factors for stroke and its subtypes in people with diabetes
have been elucidated in several studies. Most such risk factors are similar to those 
seen in the general population, that is, hypertension, an older age, the male sex, 
risk. Furthermore, higher HbA , which is a marker of poor glycemic control, is 
When it comes to microvascular complications and the stroke risk, a slight decrease 
and macroalbuminuria independently increase the risk of stroke in individuals 
independent risk factor for ischemic stroke in those with diabetes. This study did 
Dyslipidemia and cholesterol do not seem to be associated with the risk of stroke 
investigated the risk factors for stroke. In contrast to the general population 
diabetic nephropathy all independently increased the risk of any type of stroke. 
Additionally, elevated systolic blood pressure and higher HbA  increased the risk 
conducted by Davis et al, which investigated six incident strokes in individuals 
pulse. In the same study, the baseline predictors of hemorrhagic stroke were the 
diabetes duration, higher HbA , and elevated diastolic blood pressure. Notably, 
TABLE 3. Risk factors for any type of stroke in the general population and in individuals with 







Hypertension (17,21,24,265) + + + + + +
Age/Duration of diabetes (17,22,24,265) + + + + + +
Male sex (22,24,123,233,265) + + + + –
Atrial fibrillation (23,24) + + + + ?
Smoking (22,230,234,266) + + + ?
Diabetes (13,235) + + NA NA
Cholesterol (17,24,236,237,265,272) + – – +
Metabolic syndrome (25,140) + + ?
Insulin resistance (238) + NA ?
HbA1c 
(17,267,272) NA + + +
Obesity (24,239,240) + – ?
Alcohol consumption (241,242,273) + + – ?
Lack of physical activity (24,240,243) + – ?
TIA/Previous stroke (32,230,252) + + ?
Chronic kidney disease (17,245,265,268) + + +
Retinopathy (270) NA + – ?
Chronic inflammation (17,248,271) + + +
Depression and stress (249,250,274) + + ?
Aural migraine (244) + ? ?
Genetic factors (251,275,276) + + + –
Substance abuse (246,247) + ? ?





risk factor are needed before any conclusions can be drawn. 
2.3.7 Blood pressure, salt intake, and risk of stroke in  
people with diabetes
Elevated blood pressure represents one of the strongest risk factors for stroke in the 
stroke is seen in both ischemic stroke and ICH, as well in relation to both sexes. 
In addition, the risk decreases when any type of antihypertensive agent is used. 
blood pressure, mean arterial pressure, and pulse pressure) all independently 
variable associated with the stroke risk appears to be the systolic blood pressure, 
The association with stroke is not as strong for the diastolic blood pressure as 
for the systolic blood pressure. This is possibly due to the fact that the diastolic 
blood pressure does not increase with age in the same way that the systolic blood 
 Hypertension is one of the strongest 
pressure is a better predictor of the risk of cardiovascular disease in those with 
association between the systolic blood pressure and the risk of stroke is linear in 
et al showed that the risk 
with the stroke risk in the same study. In fact, the risk was increased at diastolic 
systolic blood pressure has proved to be an independent risk factor for stroke with 
which correlates strongly with the blood pressure. The same was seen for the 
fold. In contrast, for hemorrhagic stroke, the diastolic blood pressure independently 
blood pressure and the risk of stroke in these individuals.
Salt intake and risk of stroke
linked to their use of salt (or sodium intake). The gold standard measurement of 
excretion, since dietary questionnaires are prone to underestimate the salt intake 
sodium and potassium metabolism within the kidneys, thereby leading to the 
contraction of the smooth muscle cells and increased vascular resistance. The 
increased risk of cardiovascular disease and stroke. Tuomilehto et al found that 
coronary heart disease in the general population; however, no increased risk of 
et 
al, the risk of cardiovascular events, including stroke, increased when the sodium 
Not many studies have investigated the link between the salt intake and 
available are somewhat inconsistent when compared with those concerning the 
general population. Paradoxically, lower urinary sodium excretion has been found 
the incidence of cardiovascular complications, including stroke, in individuals with 
concerning the relationship between urinary sodium and potassium excretion 
2.3.8 Prognosis of stroke
has decreased alongside the incidence. However, this means that the number 
stroke in some way (i.e., death by stroke, disability, or survival after stroke) almost 
Consequences of stroke. Even though the mortality rate associated with 
stroke has decreased, stroke survivors still have to deal with the consequences 
and the symptoms depend on the size and location of the brain tissue lesion. 
The symptoms can be of a physical, emotional, or mental nature, and they can 
disabilities are similar to the acute symptoms of stroke, as discussed in section 
with seizures, and less commonly, epilepsy. This risk increases with age, and it 
Emotional disabilities after stroke can be a consequence of dementia as well as 
of the stroke itself. These disabilities include mood swings, loss of emotional 
such as depression and anxiety, are common after stroke; depression occurs in 
Survival after stroke. The mortality rate associated with stroke is high, with 
type of stroke, and hemorrhagic stroke is associated with a poorer outcome than 
ischemic stroke begins to decrease at three months after the stroke, while after 
Predictors of mortality. Naturally, an older age is one of the strongest 
predictive factors for poor survival following a stroke in the general population 
Another strong predictor of mortality following an incident stroke is diabetes 
measured as the eGFR, increases the risk of mortality after stroke when the eGFR 
. Further, impaired kidney function predicts a 
 As stated above, hemorrhagic 
stroke is associated with poorer survival than ischemic stroke. The mortality of 
hemorrhagic stroke subtypes. For both, an older age and diabetes independently 
are contradictory. Bhalla et al found the female sex to be associated with a poor 
2.3.9 Prognosis of stroke in people with diabetes
Hyperglycemia and higher HbA , without the presence of diabetes, increase 
 
fold higher if the HbA
comparing survival after stroke in individuals with and without diabetes, no 
shown to be one of the strongest predictors of severe disability and mortality after 
an ischemic stroke in those with diabetes. The risk of a poor outcome is more 
In the same study, the use of angiotensin receptor blockers as antihypertensive 
 Mortality due to cerebrovascular disease in individuals with 
of participants were still alive ten years after the stroke. Moreover, hemorrhagic 
stroke. Poor glycemic control, expressed as higher HbA  concentrations, was a 
predictor of poor survival. No association between renal dysfunction, proteinuria, 
3 AIMS OF THE STUDY
The aims of this thesis were as follows:  
I  To elucidate the incidence of stroke and its subtypes in individuals with type 
diabetic retinopathy on the risk of stroke and its subtypes. 
II To investigate the independent risk factors for stroke and the ischemic stroke, 
lacunar infarction, and hemorrhagic stroke subtypes in a large sample of 
variables and levels on the risk of stroke and the ischemic and hemorrhagic 
linearity of that risk.
an incident stroke as well as to identify the predictors of survival following a 
stroke in those individuals.
4 PARTICIPANTS AND STUDY DESIGN 
4.1 The FinnDiane Study 
All the participants in the studies included in this thesis are part of the FinnDiane 
Study, which is a nationwide, multicenter study. The study was launched in 
distribution follows the population density of Finland, with the majority of the 
population living in the south of the country. The local ethics committee of each 
center approved the study protocol, and the study was conducted in accordance 
with the Declaration of Helsinki. Each participant provided written informed 
Figure 3. Distribution of the FinnDiane Study participants. Each dot represents one FinnDiane 
participant. The distribution is similar to the geographical distribution of the population of 
Finland, with most people living in the southern parts of the country.
4.2 Identification and classification of strokes
 The participants in the FinnDiane Study who 
FinnDiane questionnaires. Second, from death certificates retrieved from 
they had been treated.
hemorrhagic or ischemic stroke by myself and my supervisor, Lena Thorn. The 
(HUS, Department of Neurology), an experienced stroke neurologist, with the 
help of Ron Liebkind (HUS, Department of Neurology). The ischemic strokes 
with a brain imaging lesion corresponding to the occlusion of a single perforating 
criteria of unilateral motor or sensory signs, or a combination of the two, involving 
at least two out of three body parts (face, arm, and leg) without the disturbance of 
into deep spontaneous hemorrhage or lobar spontaneous hemorrhage. A stroke 
A more detailed description of the strokes at baseline, as based on the 
TABLE 4. Stroke data concerning ischemic and hemorrhagic stroke
Ischemic stroke Hemorrhagic stroke
n 105 44
Age at stroke (years) 51.2 ± 9.6 48.7 ± 7.7
Follow-up time to stroke (years) 5.1 ± 2.9 4.8 ± 2.8
Stroke fatality 4 (4%) 16 (36%)*
Lacunar infarction 58 (55%) -
Deep spontaneous hemorrhage - 25 (57%)
Lobar spontaneous hemorrhage - 4 (9%)
Hemorrhage in subarachnoid space - 15 (34%)
Diagnostic imaging
   MRI performed 28 (27%) 11 (25%)
   CT performed 102 (97%) 41 (93%)
   Angiography of cervicocerebral arteries 21 (20%) 15 (34%)
   Echocardiogram performed 26 (25%) 2 (5%)*
   Carotid ultrasound performed 55 (52%) 0 (0%)*
Hospital
   University 45 (43%) 27 (61%)*
   Central 53 (50%) 14 (32%)*
   District 6 (6%) 0 (0%)
   Died at home 1 (1%) 3 (7%)*
Data are presented as mean ± standard deviation or number of cases (%). * = p < 0.05 when 
compared with ischemic stroke. MRI = magnetic resonance imaging, CT = computed tomography. 
Adapted from Hägg et al, Study I.
4.2.1 Participant selection for Studies I, II, and IV
included in the FinnDiane Study database who had no history of stroke at 
addition, two participants were excluded due to subdural hemorrhages, one due 
to traumatic hemorrhage, one due to perinatal cerebral hemorrhage, and one due 
information concerning severe diabetic retinopathy were also excluded. This 
4.2.2 Participant selection for Study III
for Study III, which was obtained from the same sources as for Studies I, II, and 
information consisted of hard cardiovascular endpoints, namely acute myocardial 
infarction, coronary artery bypass surgery, coronary angioplasty, stroke, or death 
incident stroke for each participant was collected from medical records, death 
The same exclusion criteria as applied in relation to Studies I, II, and IV were 
applied with regard to these participants. Due to unclear information on the 
information on the systolic blood pressure, three participants without information 
antihypertensive medication were excluded. Two participants without any event 
Figure 4. Flow chart of participant selection for the studies. SDR = severe diabetic retinopathy.
5 METHODS 
5.1 FinnDiane Study protocol
5.1.1 FinnDiane Study visit
At baseline, the participants all underwent a thorough clinical examination during 
a regular visit to the attending physician. Both the attending physician and the 
medical condition, medical history, medication, diabetes duration, smoking 
hip circumferences, and blood pressure were taken during the visit. In addition, 
performed. These samples were sent to the central laboratory of the FinnDiane 
Study, and more biochemical variables were measured centrally at the Helsinki 
University Hospital laboratory. 
5.1.2 Definitions of type 1 diabetes
permanent insulin medication commenced within a year following the diagnosis. 
5.1.3 Anthropometric measurements
). The waist 
circumference was measured midway between the lowest rib and the iliac crest, 
while the hip circumference was measured at the widest part of the gluteal 
region. The WHR was calculated as the waist circumference divided by the hip 
circumference. 
5.1.4 Blood pressure measurements
of these two measurements were calculated for both the systolic and diastolic blood 
diastolic blood pressure. The mean arterial pressure was calculated as the diastolic 
blood pressure +  the pulse pressure. The blood pressure measurements were 
performed using either a manual mercury sphygmomanometer or a standardized 
diuretics, or other antihypertensive agents.
5.1.5 Definition of the metabolic syndrome
and a score of three or more was considered to meet the criteria for the metabolic 
syndrome. 
5.1.6 Definition of diabetic nephropathy and assessment of  
kidney function
Each participant collected timed urine samples for the measurement of the UAER. 
dialysis treatment or having received a kidney transplant were considered to 
The eGFR was calculated based on a single serum creatinine value using the 
Women

















Stage 1 = eGFR of  90 ml/min/1.73m2
Stage 2 = eGFR of  60-89 ml/min/1.73m2
Stage 3 = eGFR of  30-59 ml/min/1.73m2
Stage 4 = eGFR of  15-29 ml/min/1.73m2
Stage 5 = eGFR of < 15 ml/min/1.73m2 or dialysis treatment
5.1.7 Definition of diabetic retinopathy
Retinal laser photocoagulation was used as a marker of severe diabetic retinopathy. 
The accuracy of this approach has previously been validated, and approximately 
proliferative retinopathy, while the remainder were treated for maculopathy or 
5.1.8 Definition of cardiovascular disease
infarction, coronary artery bypass surgery, coronary angioplasty, or treatment 
5.1.9 Medication
acid (or clopidogrel) for the primary or secondary prevention of cardiovascular 
weight heparins. 
5.1.10 Definition of smoking
cessation prior to the data collection.
5.2 Laboratory measurements and assays
5.2.1 Lipids and lipoproteins
University Hospital, Department of Medicine, Division of Cardiology, Helsinki, 
Finland. The total cholesterol and triglycerides were measured enzymatically 
Inc., Waltham, MA, USA) with kits obtained from the same manufacturer. The 
LDL-cholesterol = Total cholesterol - HDL-cholesterol - (Triglycerides/2.2)
5.2.2 Glycemic control and insulin sensitivity
The HbA  was determined locally at each study center by means of standardized 
glucose disposal rate (eGDR), a formula derived from hyperinsulinemic euglycemic 
another marker of insulin sensitivity, the total daily insulin dose divided by the 
body weight (IU/kg) was calculated. 
eGDR = 24.4 - 12.97 x WHR - 3.39 x AHT - 0.60 x HbA
1c
5.2.3 Creatinine
The serum creatinine was measured at a central laboratory by means of a kinetic 
to a photometric, enzymatic (isotope dilution mass spectrometry) method using 
A conversion formula was applied to enable the use of the results obtained 
via both methods:
S-Creatinine = (0.953 x S-Creatinine Jaffe) - 7.261
5.2.4 Urinary albumin excretion rate
The urinary albumin excretion rate was determined from at least two out of three 
La Roche, Basel, Switzerland).
5.2.5 Definition of urinary salt excretion
5.2.6 High-sensitivity C-reactive protein
serum in a central laboratory at Helsinki University Hospital using a photometric 
immunochemical method. 
5.3 Stroke information about participants in Study III
included in Study III included their HbA values, creatinine concentrations, 
renal status, presence of coronary heart disease, medication, current smoking, 
age at stroke, and duration of diabetes at the time of the incident stroke. All this 
of the stroke. If no information was available from these sources, it was obtained 
from the FinnDiane visit closest to the time of the occurrence of the stroke. 
5.4 Statistical analyses
All the variables included in the analyses were tested for the normal distribution. 
Normally distributed and continuous variables are presented as the mean ± 
5.4.1 Study I
in years for each included participant. The incidence of stroke, ischemic stroke, 
age. Separate Cox proportional hazards analyses were performed to examine how 
ischemic stroke, lacunar infarction, and hemorrhagic stroke. The separate models 
were adjusted for age, sex, systolic blood pressure, diastolic blood pressure, BMI, 
of lacunar infarction among all the ischemic strokes across the groups of kidney 
status and severe diabetic nephropathy was calculated to assess the association 
between these diabetic complications and lacunar infarction. All the analyses 
5.4.2 Study II
Cox proportional hazards analyses with forward stepwise variable entry and 
removal were performed to determine the independent risk factors for stroke, 
ischemic stroke, lacunar infarction, and hemorrhagic stroke, respectively. The 
variables that were associated with stroke in the univariate analyses were included 
in the same model due to collinearity. The main model for any type of stroke 
, waist circumference, 
diabetic nephropathy, severe diabetic retinopathy, systolic blood pressure, diastolic 
, waist circumference, 
systolic blood pressure, and diastolic blood pressure excluded, but with the eGDR 
medication included. 
of diabetes, waist circumference, systolic blood pressure, diastolic blood pressure, 
, coronary heart disease, diabetic 
nephropathy, severe diabetic retinopathy, and history of smoking. In model 
, 
waist circumference, systolic blood pressure, and diastolic blood pressure due 
In relation to lacunar infarction, similar models as used for ischemic stroke were 
, 
waist circumference, systolic blood pressure, diastolic blood pressure, triglycerides, 
with the HbA , waist circumference, systolic blood pressure, and diastolic blood 
sex, duration of diabetes, BMI, systolic blood pressure, diastolic blood pressure, 
triglycerides, diabetic nephropathy, severe diabetic retinopathy, and history of 
of diabetes due to collinearity. The results of all the models and stroke subtypes 
5.4.3 Study III
pressure variables (i.e., systolic blood pressure, diastolic blood pressure, mean 
stroke, lacunar infarction, and hemorrhagic stroke. The results are presented 
pressure variable was included in separate models. Based on the results of the 
univariate analyses, the models were adjusted for sex, duration of diabetes, waist 
circumference, diabetic nephropathy, severe diabetic retinopathy, HbA
cholesterol, current or history of smoking, and use of antihypertensive medication.
To assess the shapes of the associations between the continuous variables 
(i.e., systolic blood pressure, diastolic blood pressure, mean arterial pressure, 
hazards models with each variable included as a restricted cubic spline with three 
knots. The number of knots was selected based on the Akaike information criteria 
th th th percentiles. The HR was 
estimated based on the restricted cubic spline models and then used to create 
plots for the graphical assessment of the relationships. To determine whether the 
relationships between the blood pressure variables and the risk of stroke deviated 
from linearity, we implemented the Wald test. Similar restricted cubic spline 
5.4.4 Study IV
or hemorrhagic stroke type, as well as survival based on the chronic kidney 
disease stage at the time of the stroke. To determine which factors independently 
proportional hazards analyses. The analyses were based on the results of the 
categorical variables, or on the survival analyses. We adjusted the analyses for the 
incident stroke type (ischemic or hemorrhagic stroke), kidney status, and lacunar 
6 RESULTS
6.1 Incidence of stroke and its subtypes in people  
with type 1 diabetes (Study I)
duration of diabetes. The presence of both diabetic nephropathy and severe 
had both severe diabetic retinopathy and diabetic nephropathy when considering 
TABLE 5. Proportion of diabetic microvascular complications in participants who suffered no 










n 3,934 105 58 44
Men (%) 51 66* 69* 64
Age (years) 37.1 ± 11.8 46.1 ± 9.8* 45.1 ± 8.8* 44.0 ± 8.1*
Age at onset (years) 15.8 ± 9.0 15.3 ± 9.6 14.6 ± 9.2 14.4 ± 8.8
Duration of diabetes (years) 21.3 ± 12.1 30.8 ± 9.0* 30.5 ± 8.7* 29.6 ± 8.1*
Kidney status
Normal UAER 2,455 (62%) 19 (18%)* 10 (17%)* 8 (18%)*
Microalbuminuria 486 (12%) 18 (17%) 12 (21%)* 6 (14%)
Macroalbuminuria 499 (13%) 42 (40%)* 24 (41%)* 8 (18%)*
ESRD 241 (6%) 26 (25%)* 12 (21%)* 22 (50%)*
Microvascular complications
DN 740 (19%) 68 (65%)* 36 (62%)* 30 (68%)*
SDR 1,260 (32%) 80 (76%)* 44 (76%)* 35 (80%)*
Combined DN and SDR
Neither complication 2,392 (65%) 15 (14%)* 10 (17%)* 6 (14%)*
Only SDR 549 (15%) 22 (21%) 12 (21%) 7 (16%)
Only DN 112 (3%) 10 (10%)* 4 (7%) 2 (5%)
Both SDR and DN 634 (17%) 58 (55%)* 32 (55%)* 28 (65%)*
The data are presented as the mean ± standard deviation or number of cases (%). * = p < 0.05 
when compared with no stroke at follow-up. UAER = urinary albumin excretion rate, ESRD = end-
stage renal disease, DN = diabetic nephropathy, SDR = severe diabetic retinopathy.
Holmberg et al, previously unpublished data). The incidence of ischemic stroke and 
et 
al, previously unpublished data). The incidence of any type of stroke was higher in 
the male participants across all the age groups. The highest incidence of ischemic 
ischemic stroke was higher than the incidence of hemorrhagic stroke. Further, the 
from a stroke of the ischemic subtype. The total incidence rates for each type of 
Figure 5A. Incidence per 100,000 person-years of any type of stroke according to sex and 
age group. Men are depicted in blue, women in red.
Figure 5B. Incidence of ischemic stroke (red) and hemorrhagic stroke (green) according to age.
The incidence of stroke of any subtype, ischemic stroke, lacunar infarction, 
and hemorrhagic stroke according to the presence of diabetic nephropathy and 
advancing diabetic nephropathy, and for all the subtypes of stroke, the incidence 
incidence of any subtype of stroke was multifold in those with diabetic retinopathy 
TABLE 6. Incidence of any stroke, ischemic stroke, lacunar infarction, and hemorrhagic stroke 









Total incidence 406 (344–477) 286 (234–347) 158 (120–204) 120 (87–161)
DN
Normal UAER 122 (81–178) 86 (52–135) 45 (22–83) 36 (16–71)
Microalbuminuria 501 (321–745) 376 (223–594) 250 (129–437) 125 (46–273)
Macroalbuminuria 928 (689–1,223) 779 (562–1,053) 445 (285–663) 148 (64–292)
ESRD 1,959 (1,444–2,597) 1,061 (693–1,555) 490 (253–855) 898 (563–1,359)
SDR
No retinopathy 141 (98–198) 104 (67–154) 58 (32–98) 37 (17–71)
Retinopathy 909 (751–1,091) 632 (501–787) 348 (253–467) 277 (193–385)
The data are presented as the incidence per 100,000 person-years of follow-up with a 95% 
confidence interval. DN = diabetic nephropathy, UAER = urinary albumin excretion rate, SDR = 
severe diabetic retinopathy.
As the incidence increased with the presence of diabetic complications, we sought 
to explore how the microvascular diabetic complications of interest, namely 
risk of stroke and its subtypes. For each subgroup, we performed Cox proportional 
was found to be similar to that of the incidence for each complication and each 
subtype. The risk of stroke increased with each stage of diabetic nephropathy, 
and the presence of severe diabetic retinopathy increased the risk for all the 
TABLE 7. Cox regression analyses for any stroke, ischemic stroke, lacunar infarction, and 











Normal UAER 1.0 1.0 1.0 1.0
Microalbuminuria 3.2 (1.9–5.6) 3.3 (1.7–6.3) 4.3 (1.8–10.0) 3.2 (1.1–9.3)
Macroalbuminuria 4.9 (2.9–8.2) 5.2 (2.9–9.6) 5.7 (2.5–12.9) 3.6 (1.2–10.5)
ESRD 7.5 (4.2–13.3) 5.5 (2.7–11.3) 5.1 (1.9–14.1) 14.9 (5.5–40.9)
SDR
No retinopathy 1.0 1.0 1.0 1.0
Retinopathy 3.0 (1.9–4.5) 2.7 (1.6–4.4) 2.8 (1.5–5.5) 3.9 (1.7–8.9)
Combined DN and SDR
Neither complication 1.0 1.0 1.0 1.0
Only SDR 3.3 (1.8–5.8) 3.4 (1.7–6.6) 2.9 (1.2–6.9) 3.0 (1.0–8.9)
Only DN 7.2 (3.5–15.1) 7.9 (3.4–18.2) 5.0 (1.5–16.6) 5.3 (1.1–26.9)
Both complications 6.1 (3.6–10.3) 5.7 (3.0–10.9) 5.0 (2.2–11.3) 7.4 (2.8–19.3)
The data are presented as the hazard ratio with a 95% confidence interval. The analyses also 
included age, sex, systolic blood pressure, diastolic blood pressure, BMI, LDL- and HDL-cholesterol, 
triglycerides, and history of smoking. The reference groups were normal UAER, no SDR, and 
neither complications in the separate analyses. DN = diabetic nephropathy, UAER = urinary 
albumin excretion rate, ESRD = end-stage renal disease, SDR = severe diabetic retinopathy.
To further study the association between lacunar infarction and the microvascular 
complications, we assessed the proportion of lacunar infarctions among the 
total number of infarctions across the diabetic nephropathy and severe diabetic 
retinopathy groups as well as in relation to the combined variable. The results for 
among the total number of infarctions was similar in those with normal UAER, 
diabetic retinopathy. We did not identify any association with lacunar infarction 
or the microvascular complications in any of the groups. 
FIGURE 6. Proportion of lacunar and non-lacunar infarction among the total infarctions (i.e., 
ischemic strokes) in participants with neither complication, only severe diabetic retinopathy, 
only diabetic nephropathy, or both complications. The numbers in the bars represent the 
number of participants in each group. Copyright © 2013 American Diabetes Association from 
Diabetes Care®, Vol.36;4140-4146.  Reprinted with permission from the American Diabetes 
Association. 
6.2 Independent risk factors for stroke and its subtypes 
(Study II)
and lacunar infarction were older, had a longer duration of diabetes, had a higher 
waist circumference, had a higher total cholesterol and triglycerides, and a higher 
higher systolic and diastolic blood pressure, and they had more commonly been 
treated with antihypertensive medication and aspirin. Diabetic microvascular 
complications, coronary heart disease, the metabolic syndrome, and a history of 
seen in relation to the age at the onset of diabetes, use of warfarin medication, 
or current smoking. 
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































in order to assess the independent risk factors for each group. The variables 
higher systolic blood pressure, a longer duration of diabetes, the presence of 
diabetic nephropathy or severe diabetic retinopathy, higher HbA , and a history of 
smoking. In the separate model that included the eGDR, a lower eGDR was found 
to be independently associated with an increased risk of stroke. The same was 
seen for eGFR, while the use of antihypertensive medication also independently 
TABLE 9. Independent risk factors for any stroke type
Main model p
SBP (mmHg) 1.02 (1.01–1.03) < 0.001
Duration of diabetes (years) 1.04 (1.02–1.06) < 0.001
DN (yes/no) 2.28 (1.46–3.54) < 0.001
HbA1c (%) 1.17 (1.04–1.32) 0.010
SDR (yes/no) 1.90 (1.15–3.13) 0.012
History of smoking (yes/no) 1.58 (1.10–2.29) 0.015
Model 2 p
Duration of diabetes (years) 1.04 (1.02–1.06) < 0.001
DN (yes/no) 2.30 (1.49–3.55) < 0.001
SDR (yes/no) 1.80 (1.09–2.99) 0.022
History of smoking (yes/no) 1.50 (1.04–2.16) 0.031
eGDR (mg/kg/min) 0.83 (0.75–0.92) < 0.001
Model 3 p
SBP (mmHg) 1.02 (1.01–1.03) < 0.001
HbA1c (%) 1.15 (1.02–1.30) 0.020
SDR (yes/no) 2.74 (1.70–4.41) < 0.001
eGFR (ml/min/1.73m2) 0.99 (0.98–0.99) < 0.001
Model 4 p
SBP (mmHg) 1.02 (1.01–1.03) < 0.001
Duration of diabetes (years) 1.04 (1.02–1.06) < 0.001
DN (yes/no) 1.73 (1.09–2.74) 0.020
HbA1c (%) 1.16 (1.03–1.31) 0.016
SDR (yes/no) 1.65 (1.09–2.71) 0.046
History of smoking (yes/no) 1.56 (1.07–2.25) 0.019
AHT medication (yes/no) 2.18 (1.25–3.78) 0.006
The data are presented as the hazard ratio with a 95% confidence interval. SBP = systolic 
blood pressure, DN = diabetic nephropathy, SDR = severe diabetic retinopathy, eGDR = 
estimated glucose disposal rate, eGFR = estimated glomerular filtration rate, AHT medication 
= antihypertensive medication. Copyright © 2014 American Heart Association from Stroke®, 
Vol.45;2558-2562.  Reprinted with permission from the American Heart Association. 
The main model also included the participants’ sex, waist circumference, diastolic blood pressure, 
triglycerides, LDL-cholesterol, and coronary heart disease. Model 2 included the main model with 
the HbA1c, waist circumference, systolic blood pressure, and diastolic blood pressure excluded, 
but with the eGDR included. Model 3 included the main model with the sex and duration of 
diabetes excluded, but with the eGFR included. Model 4 included the main model with the AHT 
medication, lipid-lowering medication, and aspirin medication included.
did not prove to be an independent risk factor in any of the models. Similar risk 
factors as for ischemic stroke was seen for lacunar infarction. However, a history 
of smoking was not a risk factor for that subtype. In addition, in the model that 
included the eGFR, both severe diabetic retinopathy and a lower eGFR proved to 
risk factors for hemorrhagic stroke were found to be a lower BMI, a higher 
systolic blood pressure, diabetic nephropathy, and severe diabetic retinopathy. 
to be associated with an increased risk of hemorrhagic stroke. The duration of 
diabetes, diastolic blood pressure, triglycerides, and history of smoking were not 
associated with hemorrhagic stroke, and nor were the eGDR, antihypertensive 

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































As diabetic nephropathy proved to be a strong risk factor for stroke, we performed 
Cox proportional hazards analyses in only those participants with normal UAER 
et al, previously unpublished data). 
The male sex, a longer duration of diabetes, severe diabetic retinopathy, and 
coronary heart disease were all independent risk factors for any type of stroke in 
the participants with normal UAER. 
TABLE 11. Independent risk factors for any type of stroke in participants with a normal 
albumin excretion rate
Main model p
Sex (male) 2.79 (1.20–6.44) 0.017
Duration (years) 1.04 (1.01–1.08) 0.026
CHD (yes/no) 3.54 (1.24–10.1) 0.018
SDR (yes/no) 3.09 (1.28–7.49) 0.012
Model 2 p
CHD (yes/no) 5.35 (1.93–14.9) 0.001
SDR (yes/no) 6.39 (2.81–14.6) < 0.001
Model 3 p
CHD (yes/no) 5.14 (1.86–14.2) 0.002
SDR (yes/no) 5.65 (2.53–12.6) < 0.001
Model 4 p
CHD (yes/no) 3.54 (1.24–10.1) 0.018
SDR (yes/no) 3.08 (1.27–7.46) 0.013
Sex (male) 2.78 (1.20–6.44) 0.017
Duration of diabetes (years) 1.04 (1.01–1.08) 0.026
The data are presented as the hazard ratio with a 95% confidence interval. The main model 
included sex, duration of diabetes, coronary heart disease, severe diabetic retinopathy, and history 
of smoking. Model 2 = main model with the estimated glucose disposal rate included. Model 3 = 
main model with the sex and duration of diabetes excluded, but with the estimated glomerular 
filtration rate included. Model 4 = main model with the antihypertensive medication, lipid-lowering 
medication, and aspirin medication included. CHD = coronary heart disease, SDR = severe diabetic 
retinopathy.
6.3 Effect of blood pressure and urinary salt excretion on 
the risk of stroke (Study III)
when compared with the participants in Studies I and II. This resulted in a total 
TABLE 12. Clinical characteristics according to the blood pressure variables and antihypertensive 
medication of participants with no stroke and any type of stroke during the follow-up period
BASELINE DATA No Stroke Any Stroke
n 3,903 202
Blood pressure and urinary salt excretion
SBP (mmHg) 133 ± 18 150 ± 23*
DBP (mmHg) 79 ± 10 83 ± 11*
MAP (mmHg) 97 ± 11 105 ± 13
PP (mmHg) 54 ± 16 67 ± 19*
Hypertensive (%) 32 66*
24-h Na (mmol/l) 140 (101–185) 145 (98–192)
24-h K (mmol/l) 83 (62–105) 79 (59–104)
Na/K ratio 1.74 (1.32–2.30) 1.76 (1.45–2.33)
Antihypertensive medication
Any type of AHT medication (%) 36 78*
  - ACE inhibitor (%) 24 45*
  - Angiotensin receptor blocker (%) 5 12*
  - Calcium channel blocker (%) 11 33*
  - β blocker (%) 12 38*
  - Diuretic (%) 11 36*
  - Other (%) 1 2*
The data are presented as the mean ± standard deviation, median with interquartile range, or 
number of cases (%). * = p < 0.05 when compared with no stroke. SBP = systolic blood pressure, 
DBP = diastolic blood pressure, MAP = mean arterial pressure, PP = pulse pressure, 24-h Na = 
24-hour urinary sodium excretion, 24-h K = 24-hour urinary potassium excretion, Na/K ratio 
= sodium/potassium ratio, AHT-medication = antihypertensive medication, ACE inhibitor = 
angiotensin-converting enzyme inhibitor.
All the blood pressure variables except for the mean arterial pressure were 
the risk of stroke, we performed Cox proportional hazards analyses adjusted for the 
HbA
included in separate models due to collinearity. The results of the analyses are 
TABLE 13. Blood pressure as a risk factor for any stroke, ischemic stroke, lacunar infarction, 
and hemorrhagic stroke
Any stroke Ischemic stroke Lacunar infarction Hemorrhagic stroke
SBP 1.20 (1.11–1.29)* 1.20 (1.10–1.30)* 1.16 (1.03–1.32)* 1.21 (1.05–1.40)*
DBP 1.21 (1.03–1.41)* 1.15 (0.95–1.38) 1.09 (0.84–1.40) 1.38 (1.02–1.88)*
MAP 1.32 (1.15–1.51)* 1.29 (1.10–1.51)* 1.21 (0.97–1.52) 1.42 (1.10–1.85)*
PP 1.20 (1.10–1.31)* 1.21 (1.10–1.34)* 1.18 (1.03–1.37)* 1.16 (0.98–1.38)
The data are presented as the hazard ratio with a 95% confidence interval. The hazard ratio 
is given per 10 mmHg increase for each blood pressure variable. The model also included the 
participants’ sex, waist circumference, diabetes duration, diabetic nephropathy, HbA1c, LDL-
cholesterol, severe diabetic retinopathy, any smoking, and antihypertensive medication. The 
different blood pressure variables were included in separate models. * = p < 0.05. SBP = systolic 
blood pressure, DBP = diastolic blood pressure, MAP = mean arterial pressure, PP = pulse pressure.
increased risk of any type of stroke, while the systolic blood pressure, mean arterial 
pressure, and pulse pressure were independently associated with an increased risk 
of ischemic stroke. In terms of lacunar infarction, only the systolic blood pressure 
and pulse pressure increased the risk of that particular stroke subtype. With 
regard to hemorrhagic stroke, all the blood pressure variables except for the pulse 
pressure were independently associated with an increased risk. 
To further clarify which of the blood pressure variables had the strongest 
stroke, ischemic stroke, and lacunar infarction, while the association with the 
not shown).
stroke, as well as to investigate the blood pressure levels at which the risk of stroke 
started to increase, we performed restricted cubic splines of the Cox proportional 
hazards models. Linearity was not assumed in any of the analyses. Moreover, 
the systolic blood pressure or mean arterial pressure. However, only values at the 
was seen for any of the variables. The risk of stroke began to increase when the 
FIGURE 7. Restricted cubic spline model for any stroke and the SBP, DBP, MAP, and PP. The 
risk of any stoke in relation to (A) systolic blood pressure (SBP), (B) diastolic blood pressure 
(DBP), (C) mean arterial pressure (MAP), and (D) pulse pressure (PP), as estimated using 
restricted cubic splines models with three knots. The unadjusted hazard ratios (HRs) are 
represented by the solid line and the 95% confidence interval (CI) by the shaded area. SBP = 
systolic blood pressure, DBP = diastolic blood pressure, MAP = mean arterial pressure, PP = 
pulse pressure. Previously published in 2019 in Cardiovascular Diabetology, 18:88. Reprinted 
with the permission of the copyright holders.
In separate analyses concerning ischemic and hemorrhagic stroke and the blood 
pressure variables, similar results were obtained as were seen for any type of 
blood pressure and hemorrhagic stroke as well as for the pulse pressure and 
nor was there any trend toward a higher risk of the two stroke subtypes at the 
lower end of the blood pressure values. 
FIGURE 8. Restricted cubic spline models for ischemic and hemorrhagic stroke and the SBP, 
DBP, MAP, and PP. The risk of ischemic and hemorrhagic stroke in relation to (A) systolic 
blood pressure (SBP), (B) diastolic blood pressure (DBP), (C) mean arterial pressure (MAP), 
and (D) pulse pressure (PP), as estimated using restricted cubic spline models with three 
knots. The unadjusted hazard ratios (HRs) are represented by the solid line and the 95% 
confidence interval (CI) by the shaded area. SBP = systolic blood pressure, DBP = diastolic 
blood pressure, MAP = mean arterial pressure, PP = pulse pressure. Previously published in 
2019 in Cardiovascular Diabetology, 18:88. Reprinted with the permission of the copyright 
holders.
To explore the association between urinary sodium and potassium excretion and 
the risk of stroke, we performed Cox proportional hazards analyses. Information 
TABLE 14. 24-hour urinary sodium and potassium excretion rate as a risk factor for any stroke, 









24-h Na (per mmol/l) 0.99 (0.97–1.00) 1.00 (0.99–1.00) 1.00 (0.97–1.01) 1.00 (0.99–1.00)
24-h K (per mmol/l) 1.00 (0.99–1.01) 1.00 (0.99–1.01) 1.00 (0.99–1.01) 1.00 (0.99–1.01)
Na/K-ratio 1.03 (0.91–1.16) 0.90 (0.73–1.12) 0.98 (0.78–1.24) 1.19 (1.05–1.34)
The data are presented as the hazard ratio with a 95% confidence interval. The model also 
included the participants’ sex, waist circumference, diabetes duration, diabetic nephropathy, HbA1c, 
LDL-cholesterol, severe diabetic retinopathy, any smoking, and antihypertensive medication. The 
variables shown were included in separate models. 24-h Na = 24-hour sodium excretion rate, 24-h 
K = 24-hour potassium excretion rate, Na/K-ratio = sodium/potassium ratio. 
Restricted cubic splines of the Cox proportional hazards models were performed 
Again, linearity was not assumed in any of the analyses, and all the models were 
No increased risk of stoke was seen in the case of any stroke, which was also true 
for ischemic and hemorrhagic stroke (data for ischemic and hemorrhagic stroke 
not shown). 
FIGURE 9. Restricted cubic spline models for any stroke and the 24-h Na, 24-h K, and Na/K 
ratio. The risk of any stroke in relation to (A) 24-hour urinary sodium excretion (24-h Na), 
(B) 24-hour urinary potassium excretion (24-h K), and (C) sodium/potassium ratio (Na/K 
ratio), as estimated using restricted cubic spline models with three knots. The unadjusted 
hazard ratios (HRs) are represented by the solid line and the 95% confidence interval (CI) 
by the shaded area. Previously published in 2019 in Cardiovascular Diabetology, 18:88 as 
additional data. Reprinted with the permission of the copyright holders.
6.4 Prognosis and predictors following an incident stroke 
(Study IV)
meaning that they were excluded from the analysis. Furthermore, two participants 
participants in both groups were of a similar age at the onset of diabetes and at 
the time of the stroke. Moreover, equal proportions of both groups were men. 
The distribution of hemorrhagic stroke was similar, while lacunar infarction was 
event had a normal UAER, while a majority of those with a composite endpoint 
those with a composite endpoint. Severe diabetic retinopathy and coronary heart 
either the use of medication or current smoking habits.
TABLE 15. Characteristics at the time of the first stroke of the participants with no event when 
compared with the participants with a composite endpoint during follow-up (composite 








Men (%) 65 66
Age at onset of diabetes (years) 16.0 (8.0–26.0) 12.0 (7.0–19.5)
Duration of diabetes (years) 34.2 ± 8.9 36.2 ± 8.2
Age at stroke (years) 51.1 ± 9.5 50.4 ± 9.0
Incident hemorrhagic stroke (%) 23 31
Incident ischemic stroke (%) 78 69
   Lacunar infarction (%) 74 47*
   Non-lacunar infarction (%) 26 53*
History of TIA (%) 3 4
HbA1c (%) 8.8 ± 1.3 8.8 ± 1.7
HbA1c (mmol/mol) 72 ± 14 72 ± 18
Renal status
   Normal UAER (%) 28 10*
   Microalbuminuria (%) 25 13
   Macroalbuminuria (%) 30 21
   Kidney transplant (%) 15 40*
   Dialysis (%) 3 16*
   ESRD (%) 18 57*
eGFR (ml/min/1.73m2) 91 (58–107) 44 (26–66)*
Creatinine (μmol/l) 88 (61–115) 141 (92–219) *
CKD (%)
   Stage 1 (eGFR  90) 51 12*
   Stage 2 (eGFR 60–89) 23 22
   Stage 3 (eGFR 30–59) 18 35*
   Stage 4 (eGFR 15–30) 5 13
   Stage 5 (eGFR < 15 or dialysis) 3 19*
SDR (%) 75 86
CHD (%) 23 29
Atrial fibrillation
   Prior (%) 5 1
   At diagnosis (%) 0 2
Aspirin (%) 50 60
Warfarin (%) 5 5
Antihypertensive medication (%) 88 91
Lipid-lowering medication (%) 50 39
Current smoking (%) 23 26
The data are presented as the mean ± standard deviation, median with interquartile range, or 
number of cases (%). * = p < 0.05. TIA = transient ischemic attack, UAER = urinary albumin 
excretion rate, ESRD = end-stage renal disease, eGFR = estimated glomerular filtration rate, 
CKD = chronic kidney disease, SDR = severe diabetic retinopathy, CHD = coronary heart disease. 
Copyright © 2017 American Diabetes Association from Diabetes Care®, Vol.40;1394-1400. 
Reprinted with permission from the American Diabetes Association.
Figure 10. Flowchart of the participants who suffered an incident stroke and a composite 
event during the follow-up period. CVD-event = cardiovascular hard endpoint (acute 
myocardial infarction, coronary artery bypass surgery, or coronary angioplasty). Copyright 
© 2017 American Diabetes Association from Diabetes Care®, Vol.40;1394-1400. Reprinted 
with permission from the American Diabetes Association. 
FIGURE 11. Survival after incident stroke. (A) Overall survival after incident stroke. (B) Survival 
stratified by incident stroke type, * = p < 0.05 when compared with incident ischemic stroke. 
(C) Survival stratified by chronic kidney disease stage, * = p < 0.05 when compared with 
stage 1, † = p < 0.05 when compared with stage 5. Copyright © 2017 American Diabetes 
Association from Diabetes Care®, Vol.40;1394-1400. Printed with permission from American 
Diabetes Association
we performed Cox proportional hazards analyses to determine which variables 
function were analyzed in separate models. The results concerning the separate 
the renal status. The hemorrhagic stroke type, having received a kidney transplant, 
included the stroke subtype and the eGFR. Both hemorrhagic stroke and the eGFR 
chronic kidney disease stages rather than the renal status or eGFR. In this model, 
all independent predictors of a composite endpoint.
TABLE 16. Predictors of a composite endpoint during follow-up after an incident stroke
Hazard ratio  
for all strokes
n = 4,083





Hemorrhagic stroke (vs. ischemic) 1.63 (1.06–2.51) 0.027 - -
Non-lacunar infarction (vs. lacunar) - - 1.58 (0.99–2.54) 0.057
Renal status
   Normoalbuminuria (reference) 1.00 1.00
   Microalbuminuria 1.51 (0.66–3.46) 0.332 1.36 (0.55–3.38) 0.504
   Macroalbuminuria 1.45 (0.69–3.07) 0.331 1.30 (0.58–2.90) 0.524
   Kidney transplant 2.57 (1.27–5.17) 0.008 2.23 (1.03–4.80) 0.042
   Dialysis 4.78 (2.16–0.60) < 0.001 4.48 (1.78–11.2) 0.001
Model 2 P
Hemorrhagic stroke (vs. ischemic) 2.40 (1.52–3.79) < 0.001 - -
Non-lacunar infarction (vs. lacunar) - - 1.79 (1.09–2.94) 0.021
eGFR (ml/min/1.73m2), per unit increase 0.98 (0.97–0.99) < 0.001 0.98 (0.97–0.99) < 0.001
Model 3 P
Hemorrhagic stroke (vs. ischemic) 2.03 (1.29–3.19) 0.002 - -
Non-lacunar infarction (vs. lacunar) - - 2.00 (1.20–3.27) 0.007
CKD stage
   Stage 1 (reference) 1.00 1.00
   Stage 2 2.48 (1.17–5.24) 0.018 1.64 (0.70–3.86) 0.255
   Stage 3 3.04 (1.54–6.04) 0.001 2.72 (1.21–6.12) 0.016
   Stage 4 3.95 (1.72–9.04) 0.001 2.81 (0.98–8.02) 0.054
   Stage 5 6.71 (3.14–14.34) < 0.001 7.44 (2.86–19.3) < 0.001
The data are presented as the hazard ratio with a 95% confidence interval. The variables included 
in the models are shown in the table under the model in question. Composite endpoint = 
recurrent stroke, cardiovascular hard event, or death by cardiovascular- or diabetes-related cause. 
eGFR = estimated glomerular filtration rate, CKD = chronic kidney disease. 
Similar analyses as performed for all the stroke types were also performed for the 
predictor of a composite endpoint in the model adjusted for the eGFR and chronic 
kidney disease, but not in the model adjusted for the renal status. The other 
independent predictors of a composite endpoint in these analyses were having 
received a kidney transplant, undergoing dialysis treatment, having a lower eGFR, 
We performed similar Cox regression analyses based on the univariate 
analyses for a recurrent stroke as the endpoint as well as for a hard cardiovascular 
event as the endpoint. A higher creatinine level was the only predictor we found 
were similar to the results concerning a recurrent stroke or a hard cardiovascular 
cause mortality (data not shown). 
7 DISCUSSION
7.1 Strengths and weaknesses of the studies
Study population. All the participants included in Studies I to IV are part of 
central hospitals in Finland, and the geographical distribution of the FinnDiane 
Study centers is similar to that of the general Finnish population (see Figure 
for the FinnDiane Study. In recent years, an increasing number of individuals 
diabetic complications since such individuals are usually referred to the central 
Furthermore, the recruitment of participants for the FinnDiane Study initially 
focused on diabetic complications, especially diabetic nephropathy. 
examination protocol being followed for every participant. All the participants 
been conducted for the participant in question, by nurses and physicians at the 
information, and diabetic complications (if present) are recorded meticulously, 
and blood and urine samples are collected. The clinical data at the time of the 
incident stroke in Study IV were, however, not derived from centrally measured 
laboratory data collected during FinnDiane visits. Instead, we retrieved the data 
concerning the creatinine and HbA  levels at the time of the stroke from the 
independent predictors of survival after stroke and confounding factors exist. The 
same can be said for Study II, in which we could only examine those risk factors 
for which we had data available. Therefore, we cannot rule out the possibility 
information regarding the treatment strategies after the incident stroke was 
in this study. 
hard cardiovascular endpoint are treated in hospitals, and these endpoints are 
thoroughly documented. In the case of death outside a treatment facility, an 
autopsy is performed in some cases to determine the cause of death. Thus, we 
believe that all the events reported in this study are true events.
nephropathy in this study is based on three consecutive and timed urine collections. 
or having received a kidney transplant. A potential problem concerning the latter 
status at the time of the stroke was used, which meant that this potential bias was 
relied solely on laser treatment of the retina; therefore, milder forms of diabetic 
proliferative retinopathy or macular edema. This issue was, however, validated, as 
who underwent retinal laser treatment were treated for proliferative retinopathy, 
This study investigates symptomatic strokes. 
exclude the possibility that those participants who were considered to be free of an 
incident stroke could actually have experienced a stroke without our knowledge. 
incident stroke did indeed experience a symptomatic stroke, since all the included 
complication is, fortunately, still a relatively rare complication in this group. The 
large study population enabled us to perform analyses not only of any type of stroke, 
but also of the stroke subtypes, especially lacunar infarction. However, another 
limitation is that both intracerebral and subarachnoid hemorrhages were included 
those seen in the general population, with most subarachnoid hemorrhages being 
in that study is the same as used in the studies included in the present thesis. 
Therefore, for the studies included in this thesis, we chose to combine ICH and 
SAH into a common subtype referred to as hemorrhagic stroke. Due to the limited 
number of hemorrhagic strokes, we could not perform analyses with regard to the 
independent risk factors for the two hemorrhagic stroke subtypes. The number 
the analyses of the impact of sodium and potassium on the risk of stroke as well 
systolic blood pressure and an increased stroke risk was found, even though the 
7.2 Incidence and risk of stroke in people with type 1 
diabetes
concerning the incidence of stroke among the general population in Finland 
explores the incidence of any type of stroke in Turku, which is just a small area 
of Finland. In the Turku study, the incidence of stroke was found to vary between 
while for hemorrhagic stroke, the corresponding incidence has been reported 
hemorrhagic stroke (Study I). The incidence of ischemic and hemorrhagic stroke 
in the general population. The study population in the present study was rather 
these young individuals to have an incidence of stroke similar to that of people 
without diabetes and of a much older age. Even though the incidence of stroke 
was found to be higher in men, in terms of the multivariate analyses, the male 
sex did not appear to be a risk factor for stroke in any of the analyses (Studies I 
higher risk of cardiovascular disease and stroke seen in men among the general 
If we look closer at the incidence of stroke and its subtypes in those with type 
which is largely consistent with the results of our study. To date, only one study 
diabetes. Janghorbani et al
hemorrhagic stroke were higher in our study, which can be partly explained by 
Janghorbani et al
years found in the present study (Study I). Diabetic nephropathy might be more 
et al
incidence of lacunar infarction in this study was almost double that found in the 
study by Janghorbani et al
in the two studies could explain this incongruency. However, even though stroke 
stroke is still rather rare in those individuals. This is illustrated by the fact that 
most studies combine stroke into a common cardiovascular endpoint because the 
number of strokes in the study population is so low that subanalyses concerning 
Since the turn of the new millennium, the incidence of both cardiovascular 
of diabetic complications, especially diabetic nephropathy, which seems to 
Furthermore, the cholesterol levels seen in individuals with diabetes have also 
decline in the incidence of stroke in those with diabetes remains debatable. We did 
et al
the systolic blood pressure and albuminuria, has one of the strongest associations 
of relevant studies, the same inconsistencies in terms of the role of dyslipidemia in 
relation to the risk of stroke seen in the general population and in those with type 
for this, although the other risk factors for stroke among the general population, 
pathophysiology and the development of atherosclerosis, as explained in section 
of stroke. Even though no direct association between cholesterol concentrations 
individuals are at a high risk of developing cardiovascular disease. Therefore, the 
7.3 Effect of diabetic microvascular complications  
on the risk of stroke
proved to be diabetic nephropathy (Study II). The microvascular diabetic 
complications were, in fact, the only factors we found that independently increased 
the risk of all the stroke subtypes (Study II). In other studies elucidating the 
independent risk factors for stroke, the presence of diabetic nephropathy, 
albuminuria, or lower kidney function (measured as the eGFR) were all found 
The same was seen in studies involving a common cardiovascular endpoint, 
risk of any type of stroke, as well as of ischemic stroke, while no risk was seen 
the Pittsburgh EDC Study, we found a slightly lower risk of stroke and its subtypes. 
to be an independent risk factor for both lacunar infarction and hemorrhagic 
stroke (Study II). In the analyses not adjusted for the HbA
that milder forms of diabetic nephropathy (presented as microalbuminuria) led 
increased risk), depending on the subtype in question (Study I). The high risk 
coagulative medication, coupled with the presence of anemia in these individuals, 
also shown in our study. 
Fortunately, the association between diabetic nephropathy and the stroke risk 
possible. Regression to a lower level of albuminuria has been found to reduce the 
risk of cardiovascular events, including stroke, to the same level as that seen in 
in relation to cardiovascular disease was seen with regard to the remission of 
nephropathy and stroke, this variable represents only a crude measurement of 
kidney function, while the eGFR measures kidney function more precisely. When 
substituting diabetic nephropathy with the eGFR, a lower eGFR independently 
increased the risk of stroke in our study (Study II). Similarly, Wang et al found a 
linearly increasing risk of stroke with a declining eGFR in individuals with type 
diabetic nephropathy did not appear to be an independent risk factor for stroke, the 
that declining kidney function plays a more important role than albuminuria in 
the risk of stroke. In addition, not all individuals with diabetes and chronic kidney 
diabetic retinopathy, independently of diabetic nephropathy, increased the risk not 
only of stroke, but also of all the stroke subtypes (Study II). Surprisingly, to the best 
of our knowledge, this diabetic complication has not appeared as an independent 
risk factor for stroke in any other studies conducted among individuals with type 
individuals. Furthermore, diabetic nephropathy and diabetic retinopathy are so 
the phenotypes of diabetic retinopathy are less feasible when compared with 
risk of stroke, since the vasculature of both the retina and the kidney share the 
same pathophysiological features and mechanisms as the cerebral vasculature 
et al, retinopathy 
is considered to be a window to the cerebral vasculature, indicating that it could 
7.4 Risk factors for stroke and its subtypes
The independent risk factors for any stroke, ischemic stroke, and lacunar infarction 
were found to be quite similar, and they included a longer duration of diabetes, 
higher HbA , poor glycemic control, diabetic nephropathy, severe diabetic 
retinopathy, higher systolic blood pressure, a history of smoking, and insulin 
resistance (Study II). These risk factors are consistent with the risk factors found in 
publication of Studies I and II, other evidence has emerged. For instance, a large 
higher systolic blood pressure, higher HbA
Pease et al
with the risk factors found in our study (Study II). 
diabetes in the multivariate analyses conducted in the study by Pease et al 
while both the Pittsburgh EDC Study and Rawshani et al found a relationship 
hyperglycemia seen in cases of diabetes causes similar changes to the vasculature 
diabetes causes premature vascular aging and accelerated atherosclerosis, which 
is referred to as diabetic macroangiopathy, through several other mechanisms 
between it and stroke.
Poor glycemic control (measured as elevated HbA ) was found to be an 
independent risk factor for any type of stroke, ischemic stroke, and lacunar infarction 
role of high blood glucose levels in the development of cardiovascular disease and 
relation to these complications when the intensive treatment of the blood glucose 
in our study, where the risk of stroke and its ischemic subtypes increased with 
higher HbA  concentrations (Study II). The HbA was not, however, considered 
to be a risk factor for ischemic stroke in the Pittsburgh EDC Study, since no 
 concentrations were found between individuals who 
to increase the risk of this subtype of stroke even though diabetic nephropathy 
, diabetic microvascular 
complications, and systolic blood pressure on the stroke risk. Insulin resistance 
appeared to be an independent risk factor for any type of stroke as well as for 
et al found that insulin resistance 
increased the risk of coronary artery disease, another type of cardiovascular 
between stroke and the metabolic syndrome, a risk factor for stroke in both the 
syndrome is known to be a risk factor for cardiovascular disease and stroke in 
This could also explain the results in our study (Study II) since the presence of 
diabetic nephropathy drives the risk of stroke so strongly that it overrides the 
for the other stroke subtypes, as the diabetes duration and HbA
risk of stroke. Instead, a lower BMI increased the risk (Study II). The etiology of 
duration and higher HbA
demonstrated in the general population, where both a low and a very high BMI 
obesity paradox remains unknown. The FinnDiane Study has found that a lower 
dialysis treatment are often cachectic and anemic, and they are commonly treated 
that these individuals have an increased risk of hemorrhagic stroke. However, 
neither aspirin nor warfarin treatment increased the risk of hemorrhagic stroke 
in our study (Study II). Another factor associated with an increased risk of 
and concerns have been raised regarding statin treatment leading to overly low 
pressure on the risk of stroke and all its subtypes, even after adjusting for diabetic 
et al showed that the systolic blood 
pressure is the most important risk factor for stroke, being even more important 
pressure, pulse pressure, and mean arterial pressure) independently increased 
this risk (Study III). The pulse pressure represents an interesting blood pressure 
as a higher pulse pressure; therefore, it is no surprise that the pulse pressure 
is independently associated with an increased risk of stroke and the ischemic 
subtypes of stroke (Study III). No other studies have yet investigated the pulse 
stroke is pooled into a common cardiovascular endpoint, the pulse pressure has 
The pulse pressure, along with the systolic blood pressure, should be considered 
blood pressure seems to be strongest blood pressure component associated with 
The association between the blood pressure components and the risk of stroke 
and its subtypes proved to be linear for the systolic blood pressure and mean 
and pulse pressure (Study III). The fact that the diastolic blood pressure decreases 
found. Rawshani et al found a linear relationship between the systolic blood 
et al
in either Rawshani et al ś study or our study. Furthermore, Cederholm et al also 
found a linear association between the systolic and diastolic blood pressures 
explained by the fact that lower blood pressure levels are known to be associated 
et al, the risk of stroke in those 
The European Society of Cardiology and the American Heart Association have 
both recently published new treatment guidelines for blood pressure in individuals 
are recommended in the newly updated Current Care Guidelines for hypertension 
it could be assumed that it also increases the risk of stroke. Indeed, a higher 
with chronic kidney disease, for whom the risk of stroke increases in a linear 
and the risk of stroke was observed (Study III). Moreover, no protective role on the 
information available on their urinary sodium and potassium excretion could 
seen in the analyses, making it unlikely that increased statistical power would 
have changed the results. In addition, many participants exhibited a decline in 
7.5 Poor survival following an incident stroke
The prognosis after an incident stroke proved to be rather poor among our study 
event, and eventually, more than half the participants died during the relatively 
knowledge, the Pittsburgh EDC Study is the only study to have explicitly explored 
The participants in the Pittsburgh EDC Study were younger and had a shorter 
the applied treatment strategies as well as by the lower number of incident strokes 
et al found a 
mortality rates to those observed in older individuals were seen in the rather young 
conclude that death following a stroke occurs at a much earlier age in individuals 
than the general population. Still, there is some good news, since hospitalizations 
illustrated by the high mortality rates associated with this stroke subtype during 
eGFR, indicating that the risk of hemorrhagic stroke in individuals with diabetes is 
similar to the risk in the general population. The pathophysiology of hemorrhagic 
more extensive damage to the cerebral tissue due to edema, hypoperfusion, high 
hemorrhagic stroke, the only predictors that we found were all related to kidney 
function (i.e., diabetic nephropathy, chronic kidney disease and a lower eGFR) 
(Study IV). We are not aware of any other studies concerning this subject in those 
a composite endpoint and those without a composite endpoint in the univariate 
analyses, meaning that they were not included in the multivariate analyses. As 
seen in the other studies included in the present thesis, diabetic nephropathy and 
outcome following a stroke. Chronic kidney disease and albuminuria predict both 
disease, the risk had already increased at the point at which mildly decreased 
) was observed (Study IV). While 
Melkas et al
review conducted by Jackson et al
study by Jackson et al
(Study IV). However, Jackson et al 
relation to the subtypes of ischemic stroke was the highest immediately after 
et al
considered in the studies by Melkas et al  and Jackson et al
population. Individuals with diabetes have a higher prevalence of both systemic 
and intracranial atherosclerosis, and the prognosis after a lacunar infarction is 
and the general population is not feasible.
7.6 Is stroke a micro- or macrovascular complication?
risk of lacunar infarctions are known to increase in the presence of diabetic 
infarctions in those participants with diabetic nephropathy or severe diabetic 
lacunar infarctions and cerebral hemorrhages. In a study involving individuals 
macrovascular complication in those with diabetes. The association between 
stroke and other diabetic microvascular complications is indisputable (Studies I 
et al presented the 
diabetes, with basement membrane thickening, increased angiogenesis, increased 
macrovascular changes, such as the stenosis of the large arteries, appear to be 
regarding stroke as a microvascular complication in those with diabetes is needed, 
vacillating. 
7.7 Future prospects
Even though the questions that informed the aims of this thesis were answered, a 
few other questions were raised during the study. As diabetic nephropathy proved 
would be interesting to examine in further detail which risk factors are relevant in 
individuals with a normal UAER. In Study I, we found that the incidence of stroke 
in our study is somewhat surprising. However, this issue concerning the bias of 
both the FinnDiane and DCCT/EDIC study populations. The participants who 
do not develop albuminuria in these study populations are, in general, better 
at following health directives, have a higher socioeconomic status, and are less 
prone to developing treatment fatigue. Thus, despite the presence of diabetes, these 
UAER. Taking these matters into consideration, it appears rather problematic to 
look closer at the stroke risk in individuals with a normal UAER, at least in our 
study population. 
Another interesting question concerns the occurrence of cognitive disorders 
outcomes into consideration when we investigated the prognosis after an incident 
are risk factors for dementia, one could assume that dementia of any type would 
incident stroke. As more extensive studies concerning neurodegenerative disorders 
study population.
research. In this study, we only had the opportunity to look more closely at lacunar 
study by Thorn et al, cerebral microbleeds were found to be more common in those 
more closely study the impact of these microbleeds and the risk of ICH among the 
FinnDiane study population. As we have seen, hemorrhagic stroke in individuals 
important, therefore, to develop methods capable of identifying individuals who 
are at a high risk of hemorrhagic stroke.
This study found that microvascular diabetic complications are closely related 
kidney disease drives this risk in all the subtypes of stroke. The traditional risk 
in those with diabetes should be made. Cardiovascular disease and mortality in 
understanding when it comes to the prevention and treatment of this burden.
8 SUMMARY AND CONCLUSIONS 
8.1 Study I
The incidence of stroke and its subtypes (i.e., ischemic stroke, lacunar infarction, 
of stroke and all its subtypes increase with the presence of diabetic nephropathy 
and severe diabetic retinopathy. Moreover, both of these diabetic complications 
independently increase the risk of stroke as well as ischemic stroke, lacunar 
infarction, and hemorrhagic stroke. There is no association between lacunar 
infarction and either diabetic nephropathy or severe diabetic retinopathy.
8.2 Study II
those associated with hemorrhagic stroke. A longer duration of diabetes, diabetic 
microvascular complications, poor glycemic control, higher systolic blood pressure, 
a history of smoking, and poor insulin sensitivity are all independently associated 
with an increased risk of the ischemic subtypes of stroke. The independent 
risk factors associated with hemorrhagic stroke also include microvascular 
complications and higher systolic blood pressure, in addition to a lower body 
is important in relation to decreasing the risk of stroke in individuals with type 
8.3 Study III
All the blood pressure components (i.e., systolic blood pressure, diastolic blood 
pressure, pulse pressure, and mean arterial pressure) are associated with an 
association between both systolic blood pressure and mean arterial pressure and 
stroke and its subtypes, while the association between diastolic blood pressure 
hemorrhagic stroke increases in a linear fashion at blood pressure levels lower 
than the current treatment goals. Urinary sodium and potassium excretion do 
not have an impact on the risk of stroke or any of its subtypes. 
8.4 Study IV
individuals have an increased risk of mortality as well as a high risk of developing 
cardiovascular complications. Hemorrhagic stroke is associated with a worse 
in terms of improving survival among these individuals.
8.5 General conclusions
and have more diabetic complications, higher blood pressure, and poorer glycemic 
a stroke. The prognosis following a stroke is also poor in the former individuals, 
and glycemic control, in addition to screening for albuminuria, reduced kidney 
function, and retinopathy. Through the optimal treatment of the risk factors 
associated with stroke, as well as through the prevention of the development 
of both diabetic nephropathy and diabetic retinopathy, some strokes and their 
devastating consequences may be prevented.
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